Bephenium hydroxynaphthoate
 | |
| Systematic (IUPAC) name | |
|---|---|
| N-benzyl-N,N-dimethyl-2-phenoxyethanaminium 3-hydroxynaphthalene-2-carboxylate | |
| Clinical data | |
| |
| Oral | |
| Pharmacokinetic data | |
| Bioavailability | <1% |
| Excretion | Renal (negligible) |
| Identifiers | |
7181-73-9  3818-50-6 (hydroxynaphtoate) | |
| P02CX02 | |
| PubChem | CID 19667 |
| ChemSpider |
18524  |
| UNII |
47RU9546DX |
| ChEMBL |
CHEMBL1673148 |
| Chemical data | |
| Formula | C17H22NO+ |
| 256.36 g/mol | |
|
SMILES
| |
| |
| (what is this?) (verify) | |
Bephenium hydroxynaphthoate (INN, trade names Alcopara, Alcopar, Befenium, Debefenium, Francin, Nemex) is an anthelmintic agent formerly used in the treatment of hookworm infections and ascariasis.[1][2]
Bephenium is not FDA-approved and is not available in the United States.[3]
References
- ↑ Sweetman S (ed.) (2009). Martindale: The complete drug reference (36th ed.). London: Pharmaceutical Press. p. 143. ISBN 978-0-85369-840-1.
- ↑ Jayewardene G, Ismail MM, Wijayaratnam Y (July 1960). "Bephenium hydroxynaphthoate in treatment of ascariasis". Br Med J 2 (5194): 268–71. doi:10.1136/bmj.2.5194.268. PMC 2097409. PMID 14406934.
- ↑ Pham PA (March 19, 2009). "Bephenium hydroxynaphthoate". Point-of-Care Information Technology ABX Guide. Johns Hopkins University. Retrieved on March 25, 2011. Freely available with registration.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||